SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

CEO Troy Wilsons repeated open-market purchases of 100,000 shares have driven attention, with traders viewing the insider buying as a confidence signal and potential support for Kuras commercial launch and AML pipeline. Some remain cautious about valuation, cash burn, execution risk and the need for further KOMZIFTI sales growth and clinical data.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The token is drawing attention amid a prolonged collapse from its launch-era peak, with traders largely debating whether it was a Trump-family-linked pump-and-dump and criticizing its lack of utility. A smaller bullish group is promoting dip-buying and a potential rebound, but bearish sentiment dominates.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas sale of a minority stake in Aeroplan, combined with stronger-than-expected quarterly results and resilient travel demand, has focused attention on value unlocking, debt reduction and accelerated share buybacks. Traders are largely bullish, though some remain concerned about elevated fuel and labor costs and the airlines ongoing net debt burden.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results, raised outlook and expanded Anthropic partnership through Claudeforce have driven a sharp re-rating and renewed confidence that AI can augment rather than replace enterprise SaaS. Traders are broadly bullish and citing short covering and a broader software rotation, while skeptics argue the move is overextended and that buybacks, investments and acquisitions flatter underlying organic growth.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

The Ninth Circuits ruling that sports-event contracts are bets rather than federally regulated swaps is being viewed as a regulatory win for DraftKings, potentially limiting Kalshi and other prediction-market competition and strengthening licensed sportsbooks moat. Traders are broadly bullish on the implications, though some remain cautious about the circuit split, possible Supreme Court review, prediction-market execution, and the stocks history of failing to hold gains.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural-gas storage injections, elevated production and Freeport LNG maintenance are driving the dominant bearish discussion around BOIL, with traders arguing these supply factors are outweighing summer heat and power demand. Others anticipate a rebound if upcoming storage draws strengthen or Freeport exports recover, while many stress that contango and leveraged decay make BOIL a short-term trading vehicle rather than a long-term hold.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

Expectations for continued natural-gas weakness are driving interest in KOLD, with traders citing above-average storage, strong production, cooling weather, and reduced LNG exports during Freeport maintenance. Some participants still expect heat-driven rebounds or short squeezes, but the dominant view favors KOLD as a short-term hedge against seasonal oversupply and bearish EIA storage data.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Treasury Secretary Scott Bessents expanded long-end bond buyback plan is driving attention, with traders debating whether it can suppress elevated Treasury yields or merely provide temporary support. The discussion is further complicated by Fed Chair Kevin Warshs hawkish stance on persistent inflation, producing a split between traders expecting a bond-market short squeeze and those warning that fiscal pressures and higher-for-longer rates will keep TLT under pressure.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Anticipation of Intellia completing its rolling BLA for lonvo-z, following positive Phase 3 HAELO results in hereditary angioedema, is driving attention as traders look toward potential FDA acceptance and commercialization. The community is largely bullish on the therapys one-time gene-editing potential, while bearish participants emphasize financing, commercialization risk, and heavy short interest.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report criticizing SELLASs REGAL Phase 3 AML trial and valuation drove attention and selling, despite no new company announcement or adverse clinical data. Traders are divided between dismissing the report as a short-side hit piece and worrying that the delayed 80th event, quiet period, or forthcoming REGAL readout could signal weaker-than-expected results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


58winnfit

58WIN